Lung Cancer Screening

Lung Cancer Screening

Call for an Appointment

The nationally-ranked lung cancer program at Duke uses the latest digital imaging technology to screen for and detect lung cancer at the earliest possible stage. We use the most advanced diagnostic screening tool, low-dose CT scans. Low-dose CT is a fast, safe, noninvasive study that collects 3-D images of the lungs. These 3-D images show early-stage lung cancers that may be too small to be detected by a traditional chest X-ray. We offer appointments for lung cancer screening at convenient locations in Raleigh and Durham.

Our Doctors
Meet our doctors, view their profiles, and select the one that’s right for you.
sliders Refine Results
Use My Current Location Locations Near You
Find a Lung Cancer Screening Doctor
Matching Results
Showing of Doctors
Load More View All

Detecting Lung Cancer Early

Our comprehensive screening services address an urgent need for improved lung cancer screening and early diagnosis, when lung disease is most treatable. Screening may be appropriate for anyone with the following risk factors:

  • Age 50 years or older
  • 20 or more years of smoking history
  • Exposure to a cancer-causing substance such as radon, asbestos, silica, or another carcinogen
  • Personal history of prior lymphoma or a smoking-related tumor
  • Family history of lung cancer
  • Diagnosed with COPD or pulmonary fibrosis

Getting a lung cancer screening with low-dose CT puts you in control of your health and greatly increases your chances that lung cancer will be detected early. If you have a family history of -- or risk factors for -- lung cancer, your physician may recommend you undergo more frequent lung cancer imaging or tests.

Our Locations
Duke Health offers locations throughout the Triangle. Find one near you.

Choose Duke for Your Lung Cancer Screening

Accredited Lung Cancer Screening Program
Together, our board-certified radiologists, facilities, and CT scanners at Duke University Hospital, Duke Medicine Pavilion, and the Duke Cancer Center comprise an American College of Radiology-designated lung cancer screening center. Our scanners have undergone rigorous testing to ensure they use the lowest possible radiation doses while maintaining the highest image quality. ACR designation is given to programs that have met these rigorous standards and are run by board-certified radiologists with subspecialty training in lung cancer screening and detection.

Lung Cancer Experts
We are staffed with lung cancer experts who provide a full range of treatment options in the same clinic, five days a week.

toy phone
Call for an Appointment

Low-Dose CT Scans
Our low-dose CT scan is the most advanced diagnostic tool available today. It provides detailed results that may not be seen on traditional X-rays. The 2011 National Lung Screening Trial showed a 20 percent reduction in lung cancer-related deaths among people at high risk for developing lung cancer who were screened with low-dose CT scans compared to those who were screened with standard chest X-rays.

Same-Day Results
You learn your results during your appointment, not days later.

Support and Education
We offer smoking cessation evaluation, pulmonary rehabilitation, and counseling and support programs to help educate you about and prevent lung cancer.

Latest Technological Advances
You can access the latest technological advances in lung cancer screening at our locations in Durham and Raleigh.

Immediate Access to Lung Cancer Experts
If you are diagnosed with lung cancer, you will have immediate access to our lung cancer treatment experts, which includes a personalized treatment plan, advanced medical and surgical care, access to clinical trials, and the full spectrum of patient and family support.

Duke University Hospital is nationally ranked in 10 adult specialties
Among the Best Cancer Hospitals in U.S.
Where you receive your cancer care is important. Duke University Hospital's cancer program is ranked among the nation's best by U.S. News & World Report for 2019–2020.

Patient Resources

Reviewed: 11/22/2019